Spinal zap trial aims to help SMA patients move better
NCT ID NCT05430113
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study tested whether a temporary spinal cord stimulator (like a pacemaker for the spine) could help people with spinal muscular atrophy types 3 and 4 move their legs better. Three adults who could stand independently received the implant for up to 29 days. The goal was to see if stimulation increased muscle strength and range of motion without causing serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY TYPE 3 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New tests could reveal how SMA progresses in adults
- Smart insoles could predict fracture risk in SMA patients
- Smart insoles could reveal hidden clues in rare childhood diseases
- New Muscle-Boosting drug shows promise for SMA patients in major trial
- New fabric brace could give arm strength back to patients with muscle diseases
- Kids with chronic conditions walk stronger with VR at home